Where is 3C Patch located?

3C Patch is headquartered in Southlake, United States.

Where does 3C Patch rank among its competitors?

3C Patch ranks 63rd amongst 113 active competitors, of which 22 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Orchestra BioMed, which secured $35M in Jul, 2025.

Who are the top competitors of 3C Patch?

3C Patch's top competitors include Orchestra BioMed, Molnlycke Health Care and ConvaTec Group. Among them, Orchestra BioMed secured the most recent funding round in July, 2025.

3C Patch - 2026 Company Profile & Competitors

3C Patch is an unfunded company based in Southlake (United States), founded in 2018. It operates as a Provider of wound healing 3C Patch smart devices. 3C Patch has not raised any funding yet. The company has 113 active competitors, including 22 funded and 10 that have exited. Its top competitors include companies like Orchestra BioMed, Molnlycke Health Care and ConvaTec Group.

Company Details

3C Patch is a provider of wound healing 3C Patch smart devices. It has developed a smart device that contains patented components. It uses the proprietary high-speed centrifugation step that separates cells. It also uses coagulation Fibrin polymerizes during the coagulation step monitored by the centrifuge´s built-in optical sensor.

Website: 3cpatch.com
Email ID: *****@reapplix.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Southlake, United States

Stage

Unfunded

Ranked

63^rd among 113 active competitors

Similar Companies

Molnlycke Health Care & 45 more

View 3C Patch's full profile

3C Patch has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of 3C Patch include Orchestra BioMed, Molnlycke Health Care and ConvaTec Group. Here is the list of Top 10 competitors of 3C Patch, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Orchestra BioMed 2017, New Hope (United States), Public	Developer of medical devices for hypertension and atherosclerosis treatment	$206M	RTW Investments, Perceptive Advisors & 9 others	65/100
2nd	Molnlycke Health Care 1998, Gothenburg (Sweden), Acquired	Developer of wound care and surgical procedure solutions	-	Nordic Capital, Sierra Madre & 2 others	63/100
3rd	ConvaTec Group 1978, Reading (United Kingdom), Public	Manufacturer and supplier of devices for chronic disease management	-	Avista Capital Partners, Novo Holdings & 1 others	58/100
4th	ConvaTec 1978, Gurugram (India), Acquired	Manufacturer of medical products for wound ostomy continence infusion care	-	Ministerstvo Hospodárstva Slovenskej Republiky	57/100
5th	Royal Biologics 2015, Jersey City (United States), Series A	Innovating orthobiologics and wound care solutions for enhanced healing	$19.6M	Granite Creek Capital Partners	47/100
6th	Lepu Medical Technology 1999, Beijing (China), Public	Interventional medical devices	-	RiverHead Capital, China Reform Fund Management ... & 7 others	46/100
7th	Spectrumedics 2018, Singapore (Singapore), Series A	Manufacturer of a therapeutic device for the treatment of arterial vascular calcification	$15M	Legend Capital, Yangyun Capital & 2 others	46/100
8th	Biotronik 1963, Berlin (Germany), Funding Raised	Manufacturer of cardiac rhythm management devices, electrophysiology, and vascular intervention	-	3 Boomerang Capital, Europa & 1 others	46/100
9th	Invent Biomed 2005, Mumbai (India), Seed	Manufacturer of drug eluting stents, PTCA balloon catheters, and vascular accessories	$1M	Ladderup & 14 others	46/100
10th	Innvolution 2010, Bengaluru (India), Series B	Provider of cardiovascular and respiratory disease management through technologies and solutions	$25.8M	Orbimed & 2 others	45/100
63rd	3C Patch 2018, Southlake (United States), Unfunded	Provider of wound healing 3C Patch smart devices	-	-	23/100